Global Embolotherapy Market Growth (Status and Outlook) 2025-2031

The global Embolotherapy market size is predicted to grow from US$ 4260 million in 2025 to US$ 6488 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Global key players of Embolotherapy include Medtronic, Boston Scientific, etc. Global top 3 companies hold a share over 30%. North America is the largest market, with a share about 35%, followed by Europe and China with the share about 25% and 20%. In terms of product, Microspheres for Embolization is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer, with a share about 50%.

LPI (LP Information)' newest research report, the “Embolotherapy Industry Forecast” looks at past sales and reviews total world Embolotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Embolotherapy sales for 2025 through 2031. With Embolotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Embolotherapy industry.

This Insight Report provides a comprehensive analysis of the global Embolotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Embolotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Embolotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Embolotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Embolotherapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Embolotherapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others

Segmentation by Application:
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology

Please note: The report will take approximately 2 business days to prepare and deliver.